Global Neurostimulation Devices
Market Report
2025
The global Neurostimulation Devices market size will be USD 8740 million in 2025. Rising neurological disorder is expected to boost sales to USD 23900.98884 million by 2033, with a Compound Annual Growth Rate (CAGR) of 13.40% from 2025 to 2033.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Neurostimulation Devices Market Report 2025.
According to Cognitive Market Research, the global Neurostimulation Devices market size will be USD 8740 million in 2025. It will expand at a compound annual growth rate (CAGR) of 13.40% from 2025 to 2033.
2021 | 2025 | 2033 | CAGR | |
---|---|---|---|---|
Global Neurostimulation Devices Market Sales Revenue | 121212 | $ 8740 Million | $ 23901 Million | 13.4% |
North America Neurostimulation Devices Market Sales Revenue | 121212 | $ 3233.8 Million | $ 7887.3 Million | 11.8% |
United States Neurostimulation Devices Market Sales Revenue | 121212 | $ 2551.47 Million | 121212 | 11.6% |
Canada Neurostimulation Devices Market Sales Revenue | 121212 | $ 388.06 Million | 121212 | 12.6% |
Mexico Neurostimulation Devices Market Sales Revenue | 121212 | $ 294.28 Million | 121212 | 12.3% |
Europe Neurostimulation Devices Market Sales Revenue | 121212 | $ 2534.6 Million | $ 6453.3 Million | 12.4% |
United Kingdom Neurostimulation Devices Market Sales Revenue | 121212 | $ 425.81 Million | 121212 | 13.2% |
France Neurostimulation Devices Market Sales Revenue | 121212 | $ 233.18 Million | 121212 | 11.6% |
Germany Neurostimulation Devices Market Sales Revenue | 121212 | $ 501.85 Million | 121212 | 12.6% |
Italy Neurostimulation Devices Market Sales Revenue | 121212 | $ 217.98 Million | 121212 | 11.8% |
Russia Neurostimulation Devices Market Sales Revenue | 121212 | $ 392.86 Million | 121212 | 11.4% |
Spain Neurostimulation Devices Market Sales Revenue | 121212 | $ 207.84 Million | 121212 | 11.5% |
Sweden Neurostimulation Devices Market Sales Revenue | 121212 | $ 78.57 Million | 121212 | 12.5% |
Denmark Neurostimulation Devices Market Sales Revenue | 121212 | $ 53.23 Million | 121212 | 12.2% |
Switzerland Neurostimulation Devices Market Sales Revenue | 121212 | $ 38.02 Million | 121212 | 12% |
Luxembourg Neurostimulation Devices Market Sales Revenue | 121212 | $ 30.42 Million | 121212 | 12.7% |
Rest of Europe Neurostimulation Devices Market Sales Revenue | 121212 | $ 354.84 Million | 121212 | 11.1% |
Asia Pacific Neurostimulation Devices Market Sales Revenue | 121212 | $ 2097.6 Million | $ 7014.9 Million | 16.3% |
China Neurostimulation Devices Market Sales Revenue | 121212 | $ 880.99 Million | 121212 | 15.8% |
Japan Neurostimulation Devices Market Sales Revenue | 121212 | $ 289.47 Million | 121212 | 14.8% |
South Korea Neurostimulation Devices Market Sales Revenue | 121212 | $ 251.71 Million | 121212 | 15.4% |
India Neurostimulation Devices Market Sales Revenue | 121212 | $ 209.76 Million | 121212 | 18.2% |
Australia Neurostimulation Devices Market Sales Revenue | 121212 | $ 109.08 Million | 121212 | 15.6% |
Singapore Neurostimulation Devices Market Sales Revenue | 121212 | $ 41.95 Million | 121212 | 16.6% |
Taiwan Neurostimulation Devices Market Sales Revenue | 121212 | $ 81.81 Million | 121212 | 16.1% |
South East Asia Neurostimulation Devices Market Sales Revenue | 121212 | $ 138.44 Million | 121212 | 17.1% |
Rest of APAC Neurostimulation Devices Market Sales Revenue | 121212 | $ 94.39 Million | 121212 | 16.1% |
South America Neurostimulation Devices Market Sales Revenue | 121212 | $ 332.12 Million | $ 956 Million | 14.1% |
Brazil Neurostimulation Devices Market Sales Revenue | 121212 | $ 142.15 Million | 121212 | 14.7% |
Argentina Neurostimulation Devices Market Sales Revenue | 121212 | $ 55.8 Million | 121212 | 15% |
Colombia Neurostimulation Devices Market Sales Revenue | 121212 | $ 29.56 Million | 121212 | 13.9% |
Peru Neurostimulation Devices Market Sales Revenue | 121212 | $ 27.23 Million | 121212 | 14.3% |
Chile Neurostimulation Devices Market Sales Revenue | 121212 | $ 23.91 Million | 121212 | 14.4% |
Rest of South America Neurostimulation Devices Market Sales Revenue | 121212 | $ 53.47 Million | 121212 | 13.2% |
Middle East Neurostimulation Devices Market Sales Revenue | 121212 | $ 349.6 Million | $ 1051.6 Million | 14.8% |
Qatar Neurostimulation Devices Market Sales Revenue | 121212 | $ 27.97 Million | 121212 | 14.3% |
Saudi Arabia Neurostimulation Devices Market Sales Revenue | 121212 | $ 123.06 Million | 121212 | 15.1% |
Turkey Neurostimulation Devices Market Sales Revenue | 121212 | $ 27.97 Million | 121212 | 15.4% |
UAE Neurostimulation Devices Market Sales Revenue | 121212 | $ 72.02 Million | 121212 | 15.3% |
Egypt Neurostimulation Devices Market Sales Revenue | 121212 | $ 20.98 Million | 121212 | 14.6% |
Rest of Middle East Neurostimulation Devices Market Sales Revenue | 121212 | $ 77.61 Million | 121212 | 14% |
Africa Neurostimulation Devices Market Sales Revenue | 121212 | $ 192.28 Million | $ 537.8 Million | 13.7% |
Nigeria Neurostimulation Devices Market Sales Revenue | 121212 | $ 15.38 Million | 121212 | 13.9% |
South Africa Neurostimulation Devices Market Sales Revenue | 121212 | $ 67.68 Million | 121212 | 14.6% |
Rest of Africa Neurostimulation Devices Market Sales Revenue | 121212 | $ 109.22 Million | 121212 | 12.9% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Type Outlook: |
|
Market Split by End User |
|
Market Split by Stimulation Type |
|
Market Split by Device Type |
|
Market Split by Application |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
|
Report scope is customizable as we have a huge database of Neurostimulation Devices industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Neurostimulation Devices Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
The Neurostimulation Devices market involves technologies designed to stimulate nerves to treat a range of neurological disorders. These devices, such as deep brain stimulators, spinal cord stimulators, and transcranial magnetic stimulation units, are widely used for conditions like chronic pain, epilepsy, Parkinson's disease, and depression. With advancements in non-invasive stimulation techniques and an increasingly ageing population, the demand for neurostimulation devices is growing. The market is driven by technological innovations, rising awareness about neurological diseases, and a shift towards more effective, personalized treatments. North America currently leads the market, followed by significant growth in Europe and Asia Pacific.
In January 2024, US-based Nalu Medical successfully secured $65 million in funding through a Series E financing round. This substantial investment will fuel the development of their innovative micro-implantable neurostimulation device, a groundbreaking solution for individuals grappling with chronic pain. The funds will be instrumental in advancing clinical trials, refining the technology, and expanding the availability of this potentially life-changing treatment option for patients seeking relief from persistent pain. https://www.businesswire.com/news/home/20240103164444/en/Nalu-Medical-Inc.-Announces-65-Million-Equity-Financing-to-Advance-Treatment-for-Chronic-Neuropathic-Pain
Rising prevalence of neurological disorders will drive the growth of neurostimulation device market
The neurostimulation devices market worldwide is growing at a rapid pace with increasing neurological disorders. The increased incidence of chronic pain, epilepsy, Parkinson's disease, and depression drives demand for neurostimulation devices for treatment. Neurological disorders are increasingly prevalent all over the world, affecting a large percentage of the population.
For instance, over 3 billion individuals around the globe suffered from a neurological disorder in 2021.
https://www.who.int/news/item/14-03-2024-over-1-in-3-people-affected-by-neurological-conditions--the-leading-cause-of-illness-and-disability-worldwide
Parkinson's disease is a neurodegenerative disorder that occurs with ageing and is found in a large population of individuals worldwide. It is caused by muscles contraction, which weakens body movement, tremors, muscle rigidity, and gait. Parkinson's disease can involve more than one system of the body.
For instance, the Parkinson's Foundation reports over 10 million individuals with Parkinson’s disease worldwide. Nearly one million people in the U.S. live with Parkinson's disease. As many as about 90,000 people are estimated to receive a diagnosis for Parkinson's disease annually in the U.S.
https://www.parkinson.org/understanding-parkinsons/statistics
Neurostimulation devices, which apply electrical impulses to the nervous system, are finding more applications in the management of pain, enhancement of function, and treatment of other neurological disorders. The market for neurostimulation devices is witnessing sharp growth, owing to increasing neurological disorders. The increase in diseases such as chronic pain, epilepsy, Parkinson's disease, and depression drives demand for neurostimulation devices as treatment. Neurological disorders are increasingly prevalent around the world and are affecting a large segment of the population.
Therefore, the rising prevalence of neurological disorders will drive the growth of neurostimulation device market.
Improved miniaturization and wireless capabilities boost adoption To Boost Market Growth
The improved miniaturization and wireless capabilities of digital migraine treatment devices are key drivers boosting market growth. Advances in microelectronics and compact design have enabled more portable, user-friendly, and discreet devices, enhancing patient compliance. Wireless connectivity allows seamless integration with mobile apps, enabling remote monitoring, data tracking, and personalized treatment plans. These innovations cater to the rising demand for non-invasive migraine relief, reducing dependency on pharmaceuticals. Additionally, the growing preference for wearable, home-use devices and increasing awareness about digital therapeutics contribute to market expansion. As technology evolves, further advancements will drive wider adoption and increased market penetration.
High cost of neurostimulation devices may hamper the neurostimulation device market growth
The exorbitant expenses of neurostimulation devices and treatments are major deterrents to universal uptake, imposing financial pressure on patients as well as healthcare systems, necessitating the proper regulation of these costs. Neurostimulation devices and the procedures to accompany them, such as implantation and upkeep, are extremely costly, making them unaffordable for most patients and imposing a financial burden on healthcare systems. One of the central limitations is their high operation and initial cost, which may restrain their availability. For instance, spinal stimulators, typically indicated for chronic pain, involve costly components like electrodes and pulse generators, which imply high treatment fees. The cash pay cost for a spinal cord stimulator would be between $7,000-$10,000 depending on the practice.
https://www.physicianpartnersofamerica.com/medical-services/treatments/spinal-cord-stimulator/costs/#:~:text=Spinal%20Cord%20Stimulator%20Costs%20%22Quick%20Answers%22&text=A:%20The%20cash%20pay%20price,lower%20than%20the%20cash%20price.
The expense can serve as a major deterrent to the broader use of neurostimulation treatments, restricting the number of patients who can receive these potentially life-altering therapies. The expenses can strain patients' budgets and healthcare budgets, potentially resulting in financial hardship and rationing of care. Besides, the requirement for special training of healthcare professionals to transplant and care for these devices adds to the cost burden further. Moreover, maintenance, monitoring, and device upgrades over time are added to total costs. It is especially troublesome in regions with poor insurance coverage, as most patients will not be able to afford the remedies, which can lead to widespread adoption. The expensive nature of the neurostimulation Devices will hinder the growth of the market.
For instance, the mean per patient total reimbursement of spinal cord stimulation/peripheral nerve stimulation without pharmacotherapy was $38,187.
https://pubmed.ncbi.nlm.nih.gov/15502691/#:~:text=The%20mean%20per%20patient%20total%20reimbursement%20of,stimulation/peripheral%20nerve%20stimulation%20absent%20pharmacotherapy%20was%20$38%2C187.
Thus, high cost of neurostimulation devices may hamper the neurostimulation device market growth.
Market Trends in Neurostimulation Devices Market
Technological advancements are revolutionizing device miniaturization, connectivity, and precision treatment across various industries. Compact, lightweight designs enhance portability and user convenience, particularly in medical and wearable devices. Advanced microelectronics and nanotechnology enable more efficient performance with reduced power consumption. IoT and AI integration improve real-time monitoring, remote diagnostics, and personalized treatment solutions. Enhanced sensor technology and wireless connectivity facilitate seamless data transmission, optimizing user experience. Precision treatment benefits from AI-driven analytics and robotic-assisted procedures, improving accuracy and outcomes. These innovations drive market growth by enhancing efficiency, reducing costs, and expanding accessibility across healthcare, consumer electronics, and industrial applications.
The rising prevalence of neurological disorders, such as migraines, epilepsy, and Parkinson's disease, is fueling demand for non-invasive treatment solutions. Patients are increasingly seeking alternatives to traditional medications due to side effects and long-term dependency risks. Technological advancements in neuromodulation, wearable neurostimulation devices, and transcranial magnetic stimulation (TMS) are driving market growth. Growing awareness, favourable regulatory approvals, and integration with digital health solutions enhance accessibility and adoption. Additionally, increased investment in research and development supports innovation, while telemedicine expansion enables remote patient monitoring. These factors collectively position non-invasive treatments as a dominant trend in neurological disorder management.
We have various report editions of Neurostimulation Devices Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The neurostimulation devices market is highly competitive, with key players focusing on technological innovations, strategic partnerships, and mergers to enhance their product portfolios. Major companies such as Medtronic, Boston Scientific, Abbott, and Nevro Corporation dominate the market. They offer a range of products, including deep brain stimulation (DBS) devices, spinal cord stimulators (SCS), and transcranial magnetic stimulation (TMS) systems. These firms are investing in R&D to develop more effective and patient-friendly devices, such as wireless and rechargeable models. The market is also witnessing increasing competition from new entrants and regional players focusing on emerging markets.
In June 2024, Nexalin Technology's second-generation 15 mA neurostimulation device was approved by ANVISA, Brazil. This was the device's third clearance, following China and Oman. https://www.stocktitan.net/news/NXL/nexalin-technology-ceo-provides-letter-to-7awc57cpkubf.html
In January 2024, Abbott's Liberta RC, a cutting-edge rechargeable deep brain stimulator (DBS) system designed to alleviate movement disorders, received FDA approval. This innovative technology offers a new ray of hope for individuals grappling with conditions like Parkinson's disease and essential tremor. The Liberta RC system stands out with its unique features, including the world's smallest rechargeable implantable pulse generator (IPG) and the longest-lasting battery charge among available DBS devices. https://www.abbott.com/corpnewsroom/products-and-innovation/liberta-rc-dbs-system-is-fda-approved-3-things-to-know.html
In November 2024, Nevro Corporation introduced the groundbreaking HFX iQ Spinal Cord Stimulation System, designed to tailor the treatment of chronic pain. This system is the first and only spinal cord stimulation (SCS) device that incorporates artificial intelligence (AI) technology, utilizing high-frequency (10 kHz) therapy based on significant clinical evidence. It leverages continuous cloud data insights to provide customized pain relief.
https://nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevros-HFX-iQ-Spinal-Cord-Stimulation-with-AI-Technology-Receives-CE-Mark-Certification-in-Europe-Increasing-Product-Expansion-Globally/default.aspx
In April 2023, Synapse Biomedical Inc. obtained FDA premarket approval (PMA) for the NeuRx Diaphragm Pacing System (NeuRx DPS). This battery-operated device delivers electrical stimulation to the diaphragm through four percutaneous intramuscular electrodes, which are implanted using minimally invasive laparoscopy. It is intended to assist patients with spinal cord injuries who depend on mechanical ventilation.
https://www.synapsebiomedical.com/synapse-biomedical-wins-new-pma-approval/
In May 2023, Abbott received FDA approval for its spinal cord stimulation (SCS) systems aimed at treating chronic back pain in individuals who have not undergone or are not candidates for back surgery, referred to as non-surgical back pain. This new indication encompasses all of Abbott's SCS products available in the United States, including the Eterna SCS platform and the Proclaim SCS family.
https://abbott.mediaroom.com/2023-05-16-Abbott-Receives-FDA-Approval-for-Its-Spinal-Cord-Stimulation-Systems-to-Treat-Chronic-Back-Pain-in-People-Who-Have-Limited-Surgical-Options#:~:text=ABBOTT%20PARK%2C%20Ill.%2C%20May,surgery%2C%20known%20as%20non%2Dsurgical
In January 2023, Axonics, Inc. announced that the U.S. FDA had approved the Axonics R20 neurostimulator, an enhanced version of the Axonics R15, intended for the treatment of chronic conditions such as overactive bladder, with a lifespan of at least 20 years.
https://ir.axonics.com/news-releases/news-release-details/axonics-receives-fda-approval-fourth-generation-rechargeable#:~:text=The%20newly%20approved%20Axonics%20R20,months%20for%20only%20one%20hour
In September 2022, Neuronetics Inc. unveiled enhancements to the NeuroStar Advanced Therapy’s proprietary TrakStar Platform. The TrakStar upgrades feature a more user-friendly interface that facilitates the quick sorting and prioritization of potential patients. Additionally, it streamlines the patient experience by integrating the proprietary PHQ-10 platform with the HIPAA-compliant TrakStar patient data management system, simplifying the identification of new patients and those requiring re-treatment.
https://ir.neuronetics.com/news-releases/news-release-details/neuronetics-launches-innovations-neurostarr-advanced-therapys/
Top Companies Market Share in Neurostimulation Devices Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Research, North America region dominated the market and accounted for the highest revenue of XX% in 2022 and it is projected that it will grow at a CAGR of XX% in the future. North America is also likely to observe good growth in the neurostimulation devices market due to the growing geriatric population, the rising neurological disorders, and the strategic product launch by the top players.
For instance, according to the Parkinson's Foundation 2022 update, an estimated nearly one million individuals in the United States lived with Parkinson's disease (PD). This estimated number is predicted to increase to 1.2 million in 2030.
https://www.parkinson.org/understanding-parkinsons/statistics
Parkinson's is the second most prevalent neurodegenerative disorder after Alzheimer's disease. Therefore, the strong prevalence of neurological disorders is expected to drive market growth in North America. The presence of major players and strategic product launches, partnerships, device approvals, and collaborations are predicted to enhance market growth during the forecast period.
For instance, in December 2023, Medtronic's Percept RC neurostimulator for deep brain stimulation (DBS) received the coveted CE (Conformité Européenne) Mark.
https://news.medtronic.com/2023-12-05-Medtronic-receives-CE-Mark-for-the-Percept-RC-rechargeable-DBS-neurostimulator-with-BrainSense-technology
This innovative device, which is billed as the smallest and slimmest of its class 1-4, is notable not only for its dimensions but also for being the only rechargeable DBS system to use the revolutionary BrainSense sensing technology.
Which Region is Expanding at the Fastest CAGR?
Asia-Pacific is expected to grow at a CAGR of XX% during the forecast period. The Asia Pacific neurostimulation devices market is further sub segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The Asia Pacific market is expected to be the fastest growing among all the regions. The increasing awareness of neurological disorders across nations like India, Australia, and South Korea characterizes the market's expansion in the region. The market of neurostimulation devices in Asia Pacific is also anticipated to expand as a result of the growing development of the medical device sector in nations like Japan and China. Besides, new technology trends in neurology and the fast uptake of artificial intelligence (AI) and machine learning (ML) are some of the drivers of the market in the region. In addition, favourable government policies and research in neurology also enhance market growth.
For instance, in March 2021, Abbott introduced NeuroSphere, a virtual clinic that was used to assist deep brain stimulation patients in programming and resetting the devices at home remotely.
https://abbott.mediaroom.com/2021-03-08-Abbott-Introduces-NeuroSphere-TM-Virtual-Clinic-First-of-its-Kind-Remote-Neuromodulation-Patient-Care-Technology-in-the-U-
The current report Scope analyzes Neurostimulation Devices Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
According to Cognitive Market Research, the global Neurostimulation Devices market size was estimated at USD 8740 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 3233.80 million in 2025 and will grow at a compound annual growth rate (CAGR) of 11.8% from 2025 to 2033.
According to Cognitive Market Research, the US had a major share in the Neurostimulation Devices market with a market size of USD 2551.47 million in 2025 and is projected to grow at a CAGR of 11.6% during the forecast period. The US dominates due to advanced technology, healthcare infrastructure, and demand.
The Canadian Neurostimulation Devices market had a market share of USD 388.06 million in 2025 and is projected to grow at a CAGR of 12.6% during the forecast period. Canada's growth in neurostimulation devices is driven by technological advancements.
The Mexico Neurostimulation Devices market is projected to witness growth at a CAGR of 12.3% during the forecast period, with a market size of USD 294.28 million in 2025..
According to Cognitive Market Research, the global Neurostimulation Devices market size was estimated at USD 8740 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 2534.60 million in 2025 and will grow at a compound annual growth rate (CAGR) of 12.4% from 2025 to 2033.
The United Kingdom Neurostimulation Devices market had a market share of USD 425.81 million in 2025 and is projected to grow at a CAGR of 13.2% during the forecast period. In the UK, Neurostimulation device sales witnessed an upswing due to healthcare advancements demand.
The France Neurostimulation Devices market is projected to witness growth at a CAGR of 11.6% during the forecast period, with a market size of USD 233.18 million in 2025.
According to Cognitive Market Research, the German Neurostimulation Devices market size was valued at USD 501.85 million in 2025 and is projected to grow at a CAGR of 12.6% during the forecast period. In Germany, innovation, healthcare demand, investments
The Italy Neurostimulation Devices market is projected to witness growth at a CAGR of 11.8% during the forecast period, with a market size of USD 217.98 million in 2025.
The Russia Neurostimulation Devices market is projected to witness growth at a CAGR of 11.4% during the forecast period, with a market size of USD 392.86 million in 2025
The Spain Neurostimulation Devices market is projected to witness growth at a CAGR of 11.5% during the forecast period with a market size of USD 207.84 million in 2025
The Sweden Neurostimulation Devices market is projected to witness growth at a CAGR of 12.5% during the forecast period, with a market size of USD 78.57 million in 2025.
The Denmark Neurostimulation Devices market is projected to witness growth at a CAGR of 12.2% during the forecast period, with a market size of USD 53.23 million in 2025
The Switzerland Neurostimulation Devices market is projected to witness growth at a CAGR of 12.0% during the forecast period, with a market size of USD 38.02 million in 2025.
The Luxembourg Neurostimulation Devices market is projected to witness growth at a CAGR of 12.7% during the forecast period, with a market size of USD 30.42 million in 2025.
The Rest of Europe's Neurostimulation Devices market is projected to witness growth at a CAGR of 11.1% during the forecast period, with a market size of USD 354.84 million in 2025.
According to Cognitive Market Research, the global Neurostimulation Devices market size was estimated at USD 8740 Million, out of which APAC held the market share of around 23% of the global revenue with a market size of USD 2097.60 million in 2025 and will grow at a compound annual growth rate (CAGR) of 16.3% from 2025 to 2033.
According to Cognitive Market Research, the China Neurostimulation Devices market size was valued at USD 880.99 million in 2025 and is projected to grow at a CAGR of 15.8% during the forecast period. Neurostimulation Devices surged in China due to rising demand, innovation, the ageing population, healthcare investments, and regulatory support.
The Japan Neurostimulation Devices market is projected to witness growth at a CAGR of 14.8% during the forecast period, with a market size of USD 289.47 million in 2025
The South Korea Neurostimulation Devices market had a market share of USD 251.71 million in 2025 and is projected to grow at a CAGR of 15.4% during the forecast period. India's ageing population, rising neurological disorders, Healthcare Investments, and Technological Advancements.
The Indian Neurostimulation Devices market is projected to witness growth at a CAGR of 18.2% during the forecast period, with a market size of USD 209.76 million in 2025.
The Australian Neurostimulation Devices market is projected to witness growth at a CAGR of 15.6% during the forecast period, with a market size of USD 109.08 million in 2025.
The Singapore Neurostimulation Devices market is projected to witness growth at a CAGR of 16.6% during the forecast period, with a market size of USD 41.95 million in 2025.
The Taiwan Neurostimulation Devices market is projected to witness growth at a CAGR of 16.1% during the forecast period, with a market size of USD 81.81 million in 2025.
The South East Asia Neurostimulation Devices market is projected to witness growth at a CAGR of 17.1% during the forecast period, with a market size of USD 138.44 million in 2025.
The Rest of APAC Neurostimulation Devices market is projected to witness growth at a CAGR of 16.1% during the forecast period, with a market size of USD 94.39 million in 2025.
According to Cognitive Market Research, the global Neurostimulation Devices market size was estimated at USD 8740 Million, out of which South America held the market share of around 5% of the global revenue with a market size of USD 332.12 million in 2025 and will grow at a compound annual growth rate (CAGR) of 14.1% from 2025 to 2033.
According to Cognitive Market Research, the Brazil Neurostimulation Devices market size was valued at USD 142.15 million in 2025 and is projected to grow at a CAGR of 14.7% during the forecast period. Neurostimulation Devices flourished in Brazil due to Increasing healthcare investment.
Argentina's Neurostimulation Devices market had a market share of USD 55.80 million in 2025 and is projected to grow at a CAGR of 15.0% during the forecast period. Argentina's growth in neurostimulation devices stems from healthcare advancements and demand.
Colombia Neurostimulation Devices market is projected to witness growth at a CAGR of 13.9% during the forecast period, with a market size of USD 29.56 million in 2025
Peru Neurostimulation Devices market is projected to witness growth at a CAGR of 14.3% during the forecast period, with a market size of USD 27.23 million in 2025.
Chile Neurostimulation Devices market is projected to witness growth at a CAGR of 14.4% during the forecast period, with a market size of USD 23.91 million in 2025
The Rest of South America's Neurostimulation Devices market is projected to witness growth at a CAGR of 13.2% during the forecast period, with a market size of USD 53.47 million in 2025.
According to Cognitive Market Research, the global Neurostimulation Devices market size was estimated at USD 8740 Million, out of which the Middle East held the major market share of around 2% of the global revenue with a market size of USD 349.60 million in 2025 and will grow at a compound annual growth rate (CAGR) of 14.8% from 2025 to 2033..
The Qatar Neurostimulation Devices market is projected to witness growth at a CAGR of 14.3% during the forecast period, with a market size of USD 27.97 million in 2025. Neurostimulation Devices sales flourish due to the healthcare investments, technological advancements, and rising demand.
The Saudi Arabia Neurostimulation Devices market is projected to witness growth at a CAGR of 15.1% during the forecast period, with a market size of USD 123.06 million in 2025.
The Turkey Neurostimulation Devices market is projected to witness growth at a CAGR of 15.4% during the forecast period, with a market size of USD 27.97 million in 2025. Neurostimulation Devices sales flourished in Turkey due to increased healthcare investment.
The UAE Neurostimulation Devices market is projected to witness growth at a CAGR of 15.3% during the forecast period, with a market size of USD 72.02 million in 2025.
The Egypt Neurostimulation Devices market is projected to witness growth at a CAGR of 14.6% during the forecast period, with a market size of USD 20.98 million in 2025.
The Rest of the Middle East Neurostimulation Devices market is projected to witness growth at a CAGR of 14.0% during the forecast period, with a market size of USD 77.61 million in 2025
According to Cognitive Market Research, the global Neurostimulation Devices market size was estimated at USD 8740 Million, out of which Africa held the major market share of around 2% of the global revenue with a market size of USD 192.28 million in 2025 and will grow at a compound annual growth rate (CAGR) of 13.7% from 2025 to 2033..
The Nigeria Neurostimulation Devices market is projected to witness growth at a CAGR of 13.9% during the forecast period, with a market size of USD 15.38 million in 2025. Neurostimulation Devices sales flourish due to increased healthcare investments.
The South Africa Neurostimulation Devices market is projected to witness growth at a CAGR of 14.6% during the forecast period, with a market size of USD 67.68 million in 2025.
The Rest of Africa Neurostimulation Devices market is projected to witness growth at a CAGR of 12.9% during the forecast period, with a market size of USD 109.22 million in 2025.
Global Neurostimulation Devices Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Neurostimulation Devices Industry growth. Neurostimulation Devices market has been segmented with the help of its Type Outlook:, End User Stimulation Type, and others. Neurostimulation Devices market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
How are Segments Performing in the Global Neurostimulation Devices Market?
According to Cognitive Market Research, Pre-op skin preparation is critical in the neurostimulation devices market as it ensures optimal electrode attachment and reduces the risk of infection. By cleansing and disinfecting the skin, it enhances the efficacy of neurostimulation treatments, particularly in procedures like deep brain stimulation and spinal cord stimulation. The growing emphasis on patient safety and infection prevention in neurostimulation therapies has made pre-op skin preparation a key component, driving its adoption. This practice helps reduce complications, improve clinical outcomes, and contribute to the overall market growth by fostering trust in neurostimulation devices among healthcare providers and patients alike.
Intra-operative skin preparation is driving the fastest growth in the neurostimulation devices market by ensuring sterile conditions during surgery, reducing the risk of infections, and enhancing the overall success of neurostimulation procedures. As neurostimulation devices are increasingly used in surgeries like spinal cord stimulation, deep brain stimulation, and nerve pain management, effective skin disinfection plays a crucial role in minimizing complications and optimizing device performance. The rise in surgeries and procedures requiring neurostimulation has heightened the demand for comprehensive, reliable, and safe intra-op skin preparation, contributing to the rapid expansion of the neurostimulation devices market.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Neurostimulation Devices Industry. Request a Free Sample PDF!
According to Cognitive Market Research, Hospital operating rooms dominate the neurostimulation devices market due to the increasing use of these devices in surgical procedures. Neurostimulation is essential for treating chronic pain, neurological disorders, and movement disorders, making it integral in surgical settings. Hospitals have access to advanced equipment and a skilled workforce, which allows them to perform complex procedures using neurostimulation devices effectively. Additionally, the growing demand for minimally invasive treatments in hospitals, coupled with the increasing prevalence of conditions like Parkinson’s disease and epilepsy, contributes to the rising adoption of neurostimulation devices in hospital operating rooms, solidifying their market dominance.
In the Neurostimulation Devices Market, Hospital wards are driving the fastest growth in the Neurostimulation Devices Market due to the increasing prevalence of neurological disorders, such as Parkinson's disease, chronic pain, and epilepsy, which require advanced treatment options. The demand for neurostimulation therapies in hospital settings is rising because these devices provide effective, non-invasive solutions for managing these conditions. Additionally, technological advancements in neurostimulation devices, offering better patient outcomes with minimal side effects, are further propelling their adoption. The hospital environment provides the necessary infrastructure and expertise to implement these treatments, contributing significantly to the growth of the neurostimulation devices market.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Based on application, the global market has been categorized into pain management, epilepsy, essential tremors, urinary & fecal incontinence, depression, dystonia, gastroparesis, Parkinson’s disease, and others. Based on application, pain management segment accounted for XX% of market share in 2024. The high incidence of chronic pain diseases and increasing product use for pain management due to its high therapeutic value are the most important factors behind the expansion of this segment.
The segment is anticipated to attain the highest CAGR as well during the forecast period. Chronic pain, disk surgery pain, and leg pain are some of the diseases covered under this segment. Neurostimulation devices for pain management are a promising option, especially spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS). These technologies have the effect of providing controlled electric impulses to destination nerves, interrupting pain impulses, and as a result decreasing the perception of pain. Management of pain with neurostimulation has been particularly effective in managing chronic pain in conditions such as neuropathic pain, failed back surgery syndrome (FBSS), and complex regional pain syndrome (CRPS). Furthermore, the evolution in neurostimulation technology has brought more personalized and targeted pain management solutions, enabling customized treatment plans according to individual patient requirements. As per the recent statistics presented by the World Health Organization (2024), in 2021, around 15.4 million individuals were residing with spinal cord injuries worldwide. In addition, the FDA approval for several spinal cord stimulators for treating chronic pain is also predicted to boost segment growth.
For instance, in August 2023, Medtronic plc., a worldwide leader in healthcare technology, was granted CE mark approval for its Inceptiv closed-loop rechargeable spinal cord stimulator (SCS). It was the initial Medtronic SCS device to provide a closed-loop feature that detected each individual's individual biological signals and altered stimulation moment to moment, as necessary, to maintain therapy in sync with the movements of daily activity.
https://news.medtronic.com/2023-08-25-Medtronic-receives-CE-Mark-approval-for-Inceptiv-TM-spinal-cord-stimulator-with-closed-loop-sensing-to-treat-chronic-pain
The severe product effectiveness in managing epilepsy paired with the limited disease treatment alternatives is likely to drive the segment growth throughout the forecasting period.
For instance, Epilepsy, is a seizure-inducing neurologic illness and impacts nearly 50 million individuals worldwide, states the World Health Organization (WHO).
https://www.who.int/health-topics/epilepsy#:~:text=Epilepsy%20is%20the%20most%20common,if%20properly%20diagnosed%20and%20treated.
Essential tremors are marked by violent involuntary limb movement. The disease also involves the neck, jaw, and other parts of the body. The increasing geriatric population in the world is one of the highest impact-rendering drivers for the development of this segment. Increasing cases of depression are also expected to help the market development since neurostimulation equipment helps in easy treatment by stimulating or blocking electrical brain signals.
Research Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.
In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.
Conclusion
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Type Outlook: | Pre-op Skin Preparation, Intra-op Skin Preparation |
End User | Hospital Operating Rooms, Hospital Wards, Intensive Care Units, Ambulatory Surgical Centers, Specialty Clinics, Rehabilitation Centers |
Stimulation Type | Internal Stimulation, External Stimulation |
Device Type | SCS (Spinal Cord Stimulation) Devices, DBS (Deep Brain Stimulation) Devices, SNS (Sacral Nerve Stimulation) Devices, VNS (Vagus Nerve Stimulation) Devices, GES (Gastric Electrical Stimulation) Devices, Transcutaneous Electrical Nerve Stimulation Devices, Transcranial Magnetic Stimulation Devices, Others |
Application | Pain Management, Epilepsy, Essential Tremors, Urinary and Fecal Incontinence, Depression, Dystonia, Parkinson’s Disease, Others |
List of Competitors | Biocontrol Medical, Boston Scientific Corporation, Cyberonics Inc., Medtronic Inc., Neuronetics Inc., Neuropace Inc., Neurosigma Inc., Nevro Corporation, ST. Jude Medical Inc., Synapse Biomedical Inc. |
This chapter will help you gain GLOBAL Market Analysis of Neurostimulation Devices. Further deep in this chapter, you will be able to review Global Neurostimulation Devices Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Neurostimulation Devices. Further deep in this chapter, you will be able to review North America Neurostimulation Devices Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Neurostimulation Devices. Further deep in this chapter, you will be able to review Europe Neurostimulation Devices Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Neurostimulation Devices. Further deep in this chapter, you will be able to review Asia Pacific Neurostimulation Devices Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Neurostimulation Devices. Further deep in this chapter, you will be able to review South America Neurostimulation Devices Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Neurostimulation Devices. Further deep in this chapter, you will be able to review Middle East Neurostimulation Devices Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Neurostimulation Devices. Further deep in this chapter, you will be able to review Middle East Neurostimulation Devices Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Neurostimulation Devices. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Outlook: Analysis 2019 -2031, will provide market size split by Type Outlook:. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Outlook: Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by End User Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Stimulation Type Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Device Type Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 14 Market Split by Application Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Neurostimulation Devices market
Chapter 15 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 16 Research Methodology and Sources
Why Pre-op Skin Preparation have a significant impact on Neurostimulation Devices market? |
What are the key factors affecting the Pre-op Skin Preparation and Intra-op Skin Preparation of Neurostimulation Devices Market? |
What is the CAGR/Growth Rate of Hospital Operating Rooms during the forecast period? |
By type, which segment accounted for largest share of the global Neurostimulation Devices Market? |
Which region is expected to dominate the global Neurostimulation Devices Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|